Choroidal Neovascularization (CNV) Market 2015 will grow at a CAGR of 6.77% during 20
 

Choroidal Neovascularization (CNV) Market 2015 will grow at a CAGR of 6.77% during 2013-2018
Choroidal Neovascularization (CNV) is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the k**wn causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently ** medical treatment for this disease, this ab**rmal growth can easily lead to impairment of sight or complete loss of vision.

Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV

The report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

– Americas
– EMEA
– APAC

Key Vendors

– Bayer AG
– F. Hoffmann-La Roche Ltd.
– **vartis AG
– Regeneron Pharmaceuticals Inc.



Request For*Report Sample @ http://www.marketresearchstore.com/r...#requestSample



Other Prominent Vendors

– Affitech A/S
– Allergan Inc.
– Chengdu Kanghong Biotech Co. Ltd.
– Gilead Sciences Inc.
– Lpath Inc.
– Mat Biopharma SAS
– Pfizer Inc.
– Promedior Inc.
– QLT Inc.
– Quark Pharmaceuticals Inc.
– Resolvyx Pharmaceuticals Inc.
– Sanwa Kagaku Kenkyusho Co. Ltd.
– Valeant Pharmaceuticals International Inc.

Key Market Drivers

– High Patient and Physician Satisfaction.
– For a full, detailed list, view this report.

Key Market Challenges

– High Cost of Treatment.
– For a full, detailed list, view this report.

Key Market Trends

– Strong Competition in the Market.
– For a full, detailed list, view this report.

The post Choroidal Neovascularization (CNV) Market 2015 will grow at a CAGR of 6.77% during 2013-2018 appeared first on Medgadget.

http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs http://feeds.feedburner.com/~ff/Medg...Tc:gIN9vFwOqvQ
http://feeds.feedburner.com/~r/Medgadget/~4/iGgUCgHqySs